Prognosis of patients with ventricular tachycardia and ventricular fibrillation: role of the underlying etiology. 1988

H J Trappe, and P Brugada, and M Talajic, and P Della Bella, and R Lezaun, and R Mulleneers, and H J Wellens
Department of Cardiology, Academic Hospital Maastricht, The Netherlands.

The prognosis of 149 patients with ventricular tachycardia (n = 108) or ventricular fibrillation (n = 41) was analyzed to assess the importance of the underlying etiology of the arrhythmia. Seventy-three patients (Group I) had a previous myocardial infarction and documented late sustained monomorphic ventricular tachycardia. Thirty-five (Group II) also had a previous myocardial infarction but had late ventricular fibrillation. There were 41 patients (Group III) without coronary artery disease: 9 patients with right ventricular dysplasia, 26 with idiopathic sustained ventricular tachycardia and 6 with idiopathic ventricular fibrillation. The mean follow-up period for all patients was 22 to 57 months. The total mortality rate in Group I (16%) and Group II (34%) and the arrhythmic mortality rate in Group I (5%) and Group II (11%) were significantly higher than the rates in Group III. In the latter group the total mortality rate was 4% for those with idiopathic ventricular tachycardia and 11% for those with right ventricular dysplasia, and there were no deaths due to arrhythmia (p less than 0.05). Left ventricular ejection fraction was significantly lower and left ventricular end-diastolic pressure was significantly higher in Group I and Group II than in Group III. There were nonfatal recurrences of ventricular tachycardia in 33 to 56% of patients, and the number of these episodes did not differ significantly in those with and without coronary artery disease.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002304 Cardiac Pacing, Artificial Regulation of the rate of contraction of the heart muscles by an artificial pacemaker. Pacing, Cardiac, Artificial,Artificial Cardiac Pacing,Artificial Cardiac Pacings,Cardiac Pacings, Artificial,Pacing, Artificial Cardiac,Pacings, Artificial Cardiac
D003645 Death, Sudden The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions. Sudden Death
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H J Trappe, and P Brugada, and M Talajic, and P Della Bella, and R Lezaun, and R Mulleneers, and H J Wellens
February 1985, Vnitrni lekarstvi,
H J Trappe, and P Brugada, and M Talajic, and P Della Bella, and R Lezaun, and R Mulleneers, and H J Wellens
January 1989, Journal of cardiology. Supplement,
H J Trappe, and P Brugada, and M Talajic, and P Della Bella, and R Lezaun, and R Mulleneers, and H J Wellens
January 2018, International journal of cardiology,
H J Trappe, and P Brugada, and M Talajic, and P Della Bella, and R Lezaun, and R Mulleneers, and H J Wellens
January 1991, American heart journal,
H J Trappe, and P Brugada, and M Talajic, and P Della Bella, and R Lezaun, and R Mulleneers, and H J Wellens
April 1992, Pacing and clinical electrophysiology : PACE,
H J Trappe, and P Brugada, and M Talajic, and P Della Bella, and R Lezaun, and R Mulleneers, and H J Wellens
April 1992, Pacing and clinical electrophysiology : PACE,
H J Trappe, and P Brugada, and M Talajic, and P Della Bella, and R Lezaun, and R Mulleneers, and H J Wellens
May 1983, Pacing and clinical electrophysiology : PACE,
H J Trappe, and P Brugada, and M Talajic, and P Della Bella, and R Lezaun, and R Mulleneers, and H J Wellens
September 1992, Archives des maladies du coeur et des vaisseaux,
H J Trappe, and P Brugada, and M Talajic, and P Della Bella, and R Lezaun, and R Mulleneers, and H J Wellens
January 2018, Journal of electrocardiology,
H J Trappe, and P Brugada, and M Talajic, and P Della Bella, and R Lezaun, and R Mulleneers, and H J Wellens
August 1994, Giornale italiano di cardiologia,
Copied contents to your clipboard!